• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制剂和抗体片段作为潜在的抗炎治疗药物,针对人类疾病中的中性粒细胞蛋白酶 3。

Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.

机构信息

INSERM U-1100, Centre d'Etude des Pathologies Respiratoires and Université François Rabelais, Tours, France (B.K., C.G., F.G.); Faculty of Chemistry, University of Gdansk, Gdansk, Poland (A.L., M.W.); Architecture et Fonction des Macromolécules Biologiques, Unité Mixte de Recherche 7257, Marseille, France (C.K.); Génétique, Immunothérapie, Chimie et Cancer, Unité Mixte de Recherche 7292, Université François Rabelais, Tours, France (H.W.); Thoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, Rochester, Minnesota (U.S.); Comprehensive Pneumology Center, Institute of Lung Biology and Disease, German Center for Lung Research, Munich, Germany (D.E.J.); and Max Planck Institute of Neurobiology, Planegg-Martinsried, Germany (D.E.J.)

INSERM U-1100, Centre d'Etude des Pathologies Respiratoires and Université François Rabelais, Tours, France (B.K., C.G., F.G.); Faculty of Chemistry, University of Gdansk, Gdansk, Poland (A.L., M.W.); Architecture et Fonction des Macromolécules Biologiques, Unité Mixte de Recherche 7257, Marseille, France (C.K.); Génétique, Immunothérapie, Chimie et Cancer, Unité Mixte de Recherche 7292, Université François Rabelais, Tours, France (H.W.); Thoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Mayo Clinic and Foundation, Rochester, Minnesota (U.S.); Comprehensive Pneumology Center, Institute of Lung Biology and Disease, German Center for Lung Research, Munich, Germany (D.E.J.); and Max Planck Institute of Neurobiology, Planegg-Martinsried, Germany (D.E.J.).

出版信息

Pharmacol Rev. 2016 Jul;68(3):603-30. doi: 10.1124/pr.115.012104.

DOI:10.1124/pr.115.012104
PMID:27329045
Abstract

Proteinase 3 (PR3) has received great scientific attention after its identification as the essential antigenic target of antineutrophil cytoplasm antibodies in Wegener's granulomatosis (now called granulomatosis with polyangiitis). Despite many structural and functional similarities between neutrophil elastase (NE) and PR3 during biosynthesis, storage, and extracellular release, unique properties and pathobiological functions have emerged from detailed studies in recent years. The development of highly sensitive substrates and inhibitors of human PR3 and the creation of PR3-selective single knockout mice led to the identification of nonredundant roles of PR3 in cell death induction via procaspase-3 activation in cell cultures and in mouse models. According to a study in knockout mice, PR3 shortens the lifespan of infiltrating neutrophils in tissues and accelerates the clearance of aged neutrophils in mice. Membrane exposure of active human PR3 on apoptotic neutrophils reprograms the response of macrophages to phagocytosed neutrophils, triggers secretion of proinflammatory cytokines, and undermines immune silencing and tissue regeneration. PR3-induced disruption of the anti-inflammatory effect of efferocytosis may be relevant for not only granulomatosis with polyangiitis but also for other autoimmune diseases with high neutrophil turnover. Inhibition of membrane-bound PR3 by endogenous inhibitors such as the α-1-protease inhibitor is comparatively weaker than that of NE, suggesting that the adverse effects of unopposed PR3 activity resurface earlier than those of NE in individuals with α-1-protease inhibitor deficiency. Effective coverage of PR3 by anti-inflammatory tools and simultaneous inhibition of both PR3 and NE should be most promising in the future.

摘要

蛋白酶 3(PR3)在被确定为韦格纳肉芽肿(现称为肉芽肿性多血管炎)中抗中性粒细胞胞质抗体的重要抗原靶点后,引起了科学界的极大关注。尽管在生物合成、储存和细胞外释放过程中中性粒细胞弹性蛋白酶(NE)和 PR3 之间存在许多结构和功能上的相似之处,但近年来的详细研究揭示了它们具有独特的特性和病理生物学功能。高度敏感的 PR3 底物和抑制剂的开发以及 PR3 选择性单敲除小鼠的创建,导致在细胞培养和小鼠模型中鉴定出 PR3 通过激活半胱天冬酶-3诱导细胞死亡的非冗余作用。根据一项针对敲除小鼠的研究,PR3 通过激活半胱天冬酶-3缩短组织中浸润性中性粒细胞的寿命,并加速清除小鼠体内衰老的中性粒细胞。凋亡中性粒细胞上活性人 PR3 的膜暴露重新编程了巨噬细胞对吞噬中性粒细胞的反应,触发促炎细胞因子的分泌,并破坏免疫沉默和组织再生。PR3 诱导的吞噬作用抗炎效应的破坏不仅与多血管炎有关,而且与其他中性粒细胞周转率高的自身免疫性疾病有关。内源性抑制剂(如α-1 蛋白酶抑制剂)对膜结合 PR3 的抑制作用比对 NE 的抑制作用相对较弱,这表明在缺乏α-1 蛋白酶抑制剂的个体中,PR3 活性不受抑制的不良影响比 NE 更早出现。未来,用抗炎工具有效覆盖 PR3 并同时抑制 PR3 和 NE 应该是最有前途的。

相似文献

1
Inhibitors and Antibody Fragments as Potential Anti-Inflammatory Therapeutics Targeting Neutrophil Proteinase 3 in Human Disease.抑制剂和抗体片段作为潜在的抗炎治疗药物,针对人类疾病中的中性粒细胞蛋白酶 3。
Pharmacol Rev. 2016 Jul;68(3):603-30. doi: 10.1124/pr.115.012104.
2
New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases.用于可视化和阻断人类疾病中嗜中性粒细胞蛋白酶3的新型选择性肽基二(氯苯基)膦酸酯
J Biol Chem. 2014 Nov 14;289(46):31777-31791. doi: 10.1074/jbc.M114.591339. Epub 2014 Oct 6.
3
Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation.蛋白酶 3是肉芽肿性多血管炎的自身抗原,与凋亡中性粒细胞上的钙网织蛋白结合,损害巨噬细胞的吞噬作用,并促进炎症。
J Immunol. 2012 Sep 1;189(5):2574-83. doi: 10.4049/jimmunol.1200600. Epub 2012 Jul 27.
4
Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis.组织蛋白酶 C 失活对蛋白酶 3(自身免疫性血管炎的靶抗原)膜暴露的影响。
J Biol Chem. 2018 Aug 10;293(32):12415-12428. doi: 10.1074/jbc.RA118.001922. Epub 2018 Jun 20.
5
Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.抗蛋白酶3抗体在韦格纳肉芽肿中激活中性粒细胞:外源性花生四烯酸和白三烯B4生成的作用
J Exp Med. 1996 Oct 1;184(4):1567-72. doi: 10.1084/jem.184.4.1567.
6
A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen.基于底物的方法将 SerpinB1 转化为蛋白酶 3 的特异性抑制剂,即韦格纳肉芽肿病自身抗原。
FASEB J. 2011 Sep;25(9):3019-31. doi: 10.1096/fj.10-176552. Epub 2011 Jun 13.
7
Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.蛋白酶3,即韦格纳自身抗原,在中性粒细胞凋亡过程中被外化:与磷脂翻转酶1功能关联及干扰巨噬细胞吞噬作用的证据。
Blood. 2007 Dec 1;110(12):4086-95. doi: 10.1182/blood-2007-03-080457. Epub 2007 Aug 21.
8
Constitutive and induced forms of membrane-bound proteinase 3 interact with antineutrophil cytoplasmic antibodies and promote immune activation of neutrophils.固有型和诱导型细胞膜结合蛋白酶 3 与抗中性粒细胞胞浆抗体相互作用,促进中性粒细胞的免疫激活。
J Biol Chem. 2023 Apr;299(4):103072. doi: 10.1016/j.jbc.2023.103072. Epub 2023 Feb 26.
9
Proinflammatory genes expression in granulocytes activated by native proteinase-binding fragments of anti-proteinase 3 IgG.抗蛋白酶3 IgG的天然蛋白酶结合片段激活的粒细胞中促炎基因的表达
J Physiol Pharmacol. 2015 Aug;66(4):609-15.
10
Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.韦格纳抗原蛋白酶3在人多形核中性粒细胞细胞表面的催化活性及抑制作用
J Biol Chem. 2009 Jul 24;284(30):19896-902. doi: 10.1074/jbc.M901471200. Epub 2009 May 15.

引用本文的文献

1
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis.库普弗细胞对代谢应激肝细胞的α1抗胰蛋白酶调节异常会导致代谢相关脂肪性肝炎和肝纤维化。
Exp Mol Med. 2025 Feb;57(2):450-465. doi: 10.1038/s12276-025-01408-1. Epub 2025 Feb 12.
2
Altered Serum Alpha1-Antitrypsin Protease Inhibition before and after Clinical Hematopoietic Stem Cell Transplantation: Association with Risk for Non-Relapse Mortality.临床造血干细胞移植前后血清α1-抗胰蛋白酶蛋白酶抑制物的改变:与非复发死亡率风险的关联。
Int J Mol Sci. 2023 Dec 28;25(1):422. doi: 10.3390/ijms25010422.
3
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.
二肽基肽酶 1 抑制作为中性粒细胞介导致炎疾病的一种潜在治疗方法。
Front Immunol. 2023 Dec 14;14:1239151. doi: 10.3389/fimmu.2023.1239151. eCollection 2023.
4
GPR97 triggers inflammatory processes in human neutrophils via a macromolecular complex upstream of PAR2 activation.GPR97 通过 PAR2 激活上游的大分子复合物触发人中性粒细胞中的炎症过程。
Nat Commun. 2022 Oct 27;13(1):6385. doi: 10.1038/s41467-022-34083-1.
5
Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.蛋白酶 3 抗中性粒细胞胞质抗体在肉芽肿性多血管炎中的致病性:作为生物标志物和未来治疗方法的意义。
Front Immunol. 2021 Feb 18;12:571933. doi: 10.3389/fimmu.2021.571933. eCollection 2021.
6
4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.4C3 人源化单克隆抗体:抗中性粒细胞胞浆抗体相关性血管炎中无致病性蛋白酶 3 的概念验证
Front Immunol. 2020 Sep 25;11:573040. doi: 10.3389/fimmu.2020.573040. eCollection 2020.
7
Iterative Optimization of the Cyclic Peptide SFTI-1 Yields Potent Inhibitors of Neutrophil Proteinase 3.环肽SFTI-1的迭代优化产生了中性粒细胞蛋白酶3的强效抑制剂。
ACS Med Chem Lett. 2019 Jul 19;10(8):1234-1239. doi: 10.1021/acsmedchemlett.9b00253. eCollection 2019 Aug 8.
8
Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential.非侵入性分析肺癌中蛋白酶特异性弹力蛋白转化:生物标志物潜力。
J Cancer Res Clin Oncol. 2019 Feb;145(2):383-392. doi: 10.1007/s00432-018-2799-x. Epub 2018 Nov 22.
9
Comparing Pathways of Bradykinin Formation in Whole Blood From Healthy Volunteers and Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency.比较健康志愿者和因 C1 抑制剂缺乏导致遗传性血管性水肿患者全血中缓激肽形成途径。
Front Immunol. 2018 Oct 2;9:2183. doi: 10.3389/fimmu.2018.02183. eCollection 2018.
10
Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases.蛋白酶 3;慢性阻塞性肺疾病和其他慢性炎症性疾病的潜在靶点。
Respir Res. 2018 Sep 20;19(1):180. doi: 10.1186/s12931-018-0883-z.